Clinical trial
Dexamethasone Solution and Dexamethasone in Mucolox™ for the Treatment of Oral Inflammatory Ulcerative Diseases
NCT04540133 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexamethasone Solution and Dexamethasone in Mucolox™ for the Treatment of Oral Inflammatory Ulcerative Diseases
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 26, 2020
- Completion date
- January 6, 2023
- Enrollment
- 29 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic graft-versus-host-disease, mucous membrane pemphigoid, oral lichen planus, pemphigus vulgaris